Form D · Venture Capital Fund

MISSION BIOCAPITAL V LP

Cambridge, MA · CIK 0001810326

Offering snapshot reported Apr 13, 2021 · SEC filing

Reported sold
$192M
Indefinite offering
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 7, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 13, 2021Amendment$191,930,000No comparison0SEC filing
May 6, 2020InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$163K
Finders' fees
$0
Form D file number
021-366421

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
XT Capital Partners, LLC118719

Source: Form D, filed Apr 13, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

MISSION BIOCAPITAL V LP

Investment adviser: MISSION BIOCAPITAL MANAGEMENT COMPANY LLC

Gross asset value
$244M
Beneficial owners
128
ADV minimum commitment
$500K

Reported in Form ADV on Mar 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CARTA INVESTOR SERVICES SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP BOSTON, Massachusetts, United States
Custodian CITIZENS BANK RIVERSIDE, Rhode Island, United States Related to adviser: No
Custodian FIRST CITIZENS BANCSHARES RALEIGH, North Carolina, United States Related to adviser: No
Marketer XT CAPITAL PARTNERS, LLC WESTPORT, Connecticut, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

KPMG LLP
PCAOB 185

XT CAPITAL PARTNERS, LLC
CRD 118719 · SEC 8-53683

Filing source

Form ADV 2056312 · Mar 26, 2026 · Schedule D 7.B.(1), fund 805-5745246771

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mission Bio Capital V Gp Llc Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
139 Main Street, Suite 401
Cambridge, MA, 02142